|
Bolt Biotherapeutics, Inc. (Bolt) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Bolt Biotherapeutics, Inc. (BOLT) Bundle
Entdecken Sie die finanzielle Zukunft von Bolt Biotherapeutics, Inc. (Bolt) mit unserem benutzerfreundlichen DCF-Taschenrechner! Geben Sie Ihre Annahmen in Bezug auf Wachstum, Gewinnmargen und Ausgaben ein, um den inneren Wert von Bolt Biotherapeutics, Inc. (Bolt) zu berechnen und Ihre Anlageentscheidungen zu informieren.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .2 | .2 | 1.3 | 5.7 | 7.9 | 12.7 | 20.5 | 33.0 | 53.2 | 85.8 |
| Revenue Growth, % | 0 | 7.44 | 445.45 | 354.68 | 37.48 | 61.23 | 61.23 | 61.23 | 61.23 | 61.23 |
| EBITDA | -30.6 | -48.6 | -91.6 | -88.7 | -74.3 | -12.7 | -20.5 | -33.0 | -53.2 | -85.8 |
| EBITDA, % | -14248.37 | -21026.41 | -7269.44 | -1547.48 | -943.91 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.3 | 2.5 | 3.7 | 4.9 | 1.9 | 10.4 | 16.7 | 27.0 | 43.5 | 70.2 |
| Depreciation, % | 618.14 | 1083.98 | 291.43 | 85.37 | 23.54 | 81.78 | 81.78 | 81.78 | 81.78 | 81.78 |
| EBIT | -32.0 | -51.1 | -95.3 | -93.5 | -76.2 | -12.7 | -20.5 | -33.0 | -53.2 | -85.8 |
| EBIT, % | -14866.51 | -22110.39 | -7560.87 | -1632.85 | -967.45 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 34.8 | 22.8 | 186.2 | 168.9 | 102.2 | 12.7 | 20.5 | 33.0 | 53.2 | 85.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | -.3 | .0 | -.2 | -.8 | .0 | -3.4 | -5.5 | -8.9 | -14.4 | -23.2 |
| Inventories, % | -139.53 | -5.19 | -15.87 | -13.96 | 0 | -27.01 | -27.01 | -27.01 | -27.01 | -27.01 |
| Accounts Payable | 2.1 | 1.6 | 3.6 | 3.6 | 3.0 | 10.2 | 16.4 | 26.5 | 42.6 | 68.8 |
| Accounts Payable, % | 974.42 | 691.77 | 283.65 | 62.73 | 37.93 | 80.13 | 80.13 | 80.13 | 80.13 | 80.13 |
| Capital Expenditure | -.5 | -3.3 | -2.3 | -2.0 | -.2 | -8.6 | -13.8 | -22.2 | -35.8 | -57.8 |
| Capital Expenditure, % | -236.28 | -1412.12 | -185.56 | -34.09 | -2.62 | -67.34 | -67.34 | -67.34 | -67.34 | -67.34 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -31.5 | -60.8 | -100.9 | -91.2 | -76.2 | -12.6 | -20.3 | -32.7 | -52.8 | -85.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.2 | -62.3 | -97.4 | -87.6 | -76.0 | -.1 | -9.0 | -14.5 | -23.4 | -37.8 |
| WACC, % | 6.1 | 6.13 | 6.13 | 6.08 | 6.13 | 6.12 | 6.12 | 6.12 | 6.12 | 6.12 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -66.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -39 | |||||||||
| Terminal Value | -937 | |||||||||
| Present Terminal Value | -696 | |||||||||
| Enterprise Value | -763 | |||||||||
| Net Debt | 9 | |||||||||
| Equity Value | -772 | |||||||||
| Diluted Shares Outstanding, MM | 38 | |||||||||
| Equity Value Per Share | -20.43 |
What You Will Get
- Real Bolt Biotherapeutics Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Bolt Biotherapeutics, Inc. (BOLT).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates tailored to BOLT.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Bolt Biotherapeutics’ fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to BOLT.
- Time-Saving and Accurate: Skip building models from scratch while ensuring precision and flexibility for Bolt Biotherapeutics, Inc. (BOLT).
Key Features
- 🔍 Real-Life BOLT Financials: Pre-filled historical and projected data for Bolt Biotherapeutics, Inc. (BOLT).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Bolt’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Bolt’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Model: Download and open the Excel file featuring Bolt Biotherapeutics, Inc.’s (BOLT) preloaded financial data.
- 2. Adjust Key Variables: Modify essential inputs such as projected growth rates, WACC, and capital expenditures.
- 3. Analyze Results in Real-Time: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Explore Different Scenarios: Evaluate various forecasts to assess different valuation possibilities.
- 5. Make Informed Decisions: Present detailed valuation analyses to back your strategic choices.
Why Choose This Calculator for Bolt Biotherapeutics, Inc. (BOLT)?
- Comprehensive Tool: Combines DCF, WACC, and financial ratio analyses tailored for biotechnology firms.
- Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
- Detailed Insights: Automatically computes Bolt Biotherapeutics' intrinsic value and Net Present Value.
- Preloaded Data: Access to historical and projected data ensures reliable analysis.
- Professional Quality: Perfect for financial analysts, biotech investors, and corporate consultants.
Who Should Use This Product?
- Biotech Students: Understand drug development processes and apply them using real-world data.
- Researchers: Integrate advanced therapeutic models into academic studies or clinical research.
- Investors: Evaluate your own strategies and assess valuation metrics for Bolt Biotherapeutics, Inc. (BOLT).
- Industry Analysts: Enhance your analysis with a customizable model tailored for biotech evaluations.
- Pharmaceutical Entrepreneurs: Discover how large biotech firms like Bolt Biotherapeutics, Inc. (BOLT) are assessed in the market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Bolt Biotherapeutics, Inc. (BOLT).
- Real-World Data: Bolt Biotherapeutics’ historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.